Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

After hours: March 18 at 7:59:54 PM EDT Loading Chart for MRNA ...

A few years ago, Moderna (NASDAQ: MRNA) stock soared on the back of the highly successful vaccine it developed in record time. At its peak in 2021, Moderna traded for over $450 per share.

Former central bank official says China can take up position abdicated by US if it adopts a strategy of mutual benefit in climate policy. An employee makes clothes at a factory in eastern China ...

China, Iran and Russia called for diplomacy over “pressure and threats” and an end to “all illegal unilateral sanctions” following talks on Tehran’s nuclear program Friday in Beijing ...

Following China’s unannounced naval exercises off the coast of Australia late last month, there has been a noticeable increase in Chinese social media content promoting the invasion (or ...

Latest news, features and opinion on China’s technology industry, including AI, the US-China tech war, 5G, smartphone makers and apps, and issues surrounding China’s Great Firewall.

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.